Altasciences Wins Most Successful Early Phase Research (Preclinical & Phase I) at the 2019 CARE Awards

LAVAL, Québec–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Altasciences?src=hash" target="_blank"gt;#Altascienceslt;/agt;–Altasciences won in the Most Successful Early Phase Research
(Preclinical & Phase I) category at the 2019 Clinical and Research
Excellence (CARE) Awards. The award win was announced during a ceremony
presented by Ben Nemzer at the Hyatt Regency Boston, US on May 2, 2019.

Now in its fourth year, the CARE Awards drew a crowd of pharmaceutical
and biomedtech industry leaders and innovators from companies both large
and small, who gathered to celebrate the achievements of those working
to advance the quality of healthcare worldwide by bringing new and
needed medicines to market. Categories for the awards spanned the full
spectrum of the drug development process, and the winners of these
prestigious trophies were as diverse as the categories themselves.

Altasciences undertook an innovative approach to identify and recruit
asymptomatic patients with nonalcoholic steatohepatitis or NASH, a
disease for which recruitment competition is quite high. This project
required creative and insightful thinking, analysis and preparation to
proactively build a patient database for a condition that is
asymptomatic, for which affected patients lack awareness and hence
motivation to participate in a clinical trial. The upfront investment of
effort paid off. Despite joining the trial 2 months behind other sites,
Altasciences became the top enrolling site, recruiting more than 35% of
the overall patients.

“I am proud of our team’s unwavering commitment and passion to
bringing better and more cost effective drugs to the people who need
them, faster. This recognition by the industry of our ability to provide
innovative solutions and of our effective participant recruitment and
retention strategies reflects Altasciences’ ongoing drive to meet and
exceed sponsor expectations,” stated Chris Perkin, CEO, at
Altasciences.

To see the full list of CARE Awards winners please visit: https://pharmaintelligence.informa.com/events/awards/care-awards-2019

About Altasciences
Altasciences
is a forward-thinking, mid-size contract research organization offering
pharmaceutical and biotechnology companies of all sizes a proven,
flexible approach to preclinical and early phase clinical studies, from
lead candidate selection to proof of concept. For over 25 years,
Altasciences has been partnering with sponsors to help support educated,
faster, and more complete early drug development decisions.
Altasciences’ full-service solutions include preclinical safety testing,
clinical pharmacology and proof of concept, bioanalysis, program
management, medical writing, biostatistics, and data management, all
customizable to specific sponsor requirements. Altasciences helps
sponsors get better drugs to the people who need them, faster.

About Informa Pharma Intelligence
Trusted by over 3,000 of
the world’s leading pharmaceutical companies, CROs, med and biotech
organizations, and healthcare service providers, the Pharma Intelligence
suite of intelligence solutions delivers vital, accurate, and timely
intelligence about the drug development pipeline to pharmaceutical and
biomedical decision makers around the world. At Pharma Intelligence,
global teams of subject area experts follow and analyze key diseases,
clinical trials, drug approvals and R&D activities as part of the
breadth and depth of data available to customers.

Contacts

Julie-Ann Cabana
Altasciences
913 304-4505
[email protected]